These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28168601)

  • 1. Long-term follow-up after active surveillance or curative treatment: quality-of-life outcomes of men with low-risk prostate cancer.
    Venderbos LDF; Aluwini S; Roobol MJ; Bokhorst LP; Oomens EHGM; Bangma CH; Korfage IJ
    Qual Life Res; 2017 Jun; 26(6):1635-1645. PubMed ID: 28168601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in men with prostate cancer undergoing active surveillance versus radical prostatectomy, external-beam radiotherapy, prostate brachytherapy and reference population: a cross-sectional study.
    Sureda A; Fumadó L; Ferrer M; Garín O; Bonet X; Castells M; Mir MC; Abascal JM; Vigués F; Cecchini L; Suárez JF
    Health Qual Life Outcomes; 2019 Jan; 17(1):11. PubMed ID: 30642340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual function with localized prostate cancer: active surveillance vs radical therapy.
    van den Bergh RC; Korfage IJ; Roobol MJ; Bangma CH; de Koning HJ; Steyerberg EW; Essink-Bot ML
    BJU Int; 2012 Oct; 110(7):1032-9. PubMed ID: 22260273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy.
    Banerji JS; Hurwitz LM; Cullen J; Wolff EM; Levie KE; Rosner IL; Brand TC; LʼEsperance JO; Sterbis JR; Porter CR
    Urol Oncol; 2017 May; 35(5):234-242. PubMed ID: 28110975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P).
    Waldmann A; Rohde V; Bremner K; Krahn M; Kuechler T; Katalinic A
    BMC Cancer; 2009 Aug; 9():295. PubMed ID: 19698163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer.
    Egger SJ; Calopedos RJ; O'Connell DL; Chambers SK; Woo HH; Smith DP
    Eur Urol; 2018 Jun; 73(6):859-867. PubMed ID: 28851582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy.
    Jeldres C; Cullen J; Hurwitz LM; Wolff EM; Levie KE; Odem-Davis K; Johnston RB; Pham KN; Rosner IL; Brand TC; L'Esperance JO; Sterbis JR; Etzioni R; Porter CR
    Cancer; 2015 Jul; 121(14):2465-73. PubMed ID: 25845467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact on quality of life of radical prostatectomy after initial active surveillance: more to lose?
    van den Bergh RC; de Blok W; van Muilekom E; Tillier C; Venderbos LD; van der Poel HG
    Scand J Urol; 2014 Aug; 48(4):367-73. PubMed ID: 24506062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.
    Lardas M; Liew M; van den Bergh RC; De Santis M; Bellmunt J; Van den Broeck T; Cornford P; Cumberbatch MG; Fossati N; Gross T; Henry AM; Bolla M; Briers E; Joniau S; Lam TB; Mason MD; Mottet N; van der Poel HG; Rouvière O; Schoots IG; Wiegel T; Willemse PM; Yuan CY; Bourke L
    Eur Urol; 2017 Dec; 72(6):869-885. PubMed ID: 28757301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer.
    Kyrdalen AE; Dahl AA; Hernes E; Småstuen MC; Fosså SD
    BJU Int; 2013 Feb; 111(2):221-32. PubMed ID: 22672151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term quality of life among localised prostate cancer survivors: QALIPRO population-based study.
    Kerleau C; Guizard AV; Daubisse-Marliac L; Heutte N; Mercier M; Grosclaude P; Joly F;
    Eur J Cancer; 2016 Aug; 63():143-53. PubMed ID: 27318002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life.
    Jo Y; Junichi H; Tomohiro F; Yoshinari I; Masato F
    BJU Int; 2005 Jul; 96(1):43-7. PubMed ID: 15963118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and satisfaction with information after radical prostatectomy, radical external beam radiotherapy and postoperative radiotherapy: a long-term follow-up study.
    Nicolaisen M; Müller S; Patel HR; Hanssen TA
    J Clin Nurs; 2014 Dec; 23(23-24):3403-14. PubMed ID: 24890131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of age on quality-of-life outcomes after treatment for localized prostate cancer.
    Hampson LA; Cowan JE; Zhao S; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Sep; 68(3):480-6. PubMed ID: 25656807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary and sexual outcomes in long-term (5+ years) prostate cancer disease free survivors after radical prostatectomy.
    Gacci M; Simonato A; Masieri L; Gore JL; Lanciotti M; Mantella A; Rossetti MA; Serni S; Varca V; Romagnoli A; Ambruosi C; Venzano F; Esposito M; Montanaro T; Carmignani G; Carini M
    Health Qual Life Outcomes; 2009 Nov; 7():94. PubMed ID: 19912640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late urinary morbidity and quality of life after radical prostatectomy and salvage radiotherapy for prostate cancer
    Ervandian M; Høyer M; Petersen SE; Sengeløv L; Hansen S; Kempel MM; Meidahl Petersen P; Borre M
    Scand J Urol; 2017 Dec; 51(6):457-463. PubMed ID: 28748716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study.
    Bergengren O; Garmo H; Bratt O; Holmberg L; Johansson E; Bill-Axelson A
    Eur Urol Oncol; 2018 May; 1(1):37-45. PubMed ID: 31100227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
    Bradley EB; Bissonette EA; Theodorescu D
    BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels.
    Venderbos LD; van den Bergh RC; Roobol MJ; Schröder FH; Essink-Bot ML; Bangma CH; Steyerberg EW; Korfage IJ
    Psychooncology; 2015 Mar; 24(3):348-54. PubMed ID: 25138075
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.